Key Highlights

  • AIP shares are down roughly 9.22% today to $25.27, from a prior close near $27.84, extending a sharp pullback from a 2026 high above $50 reached earlier this summer.
  • The stock has been under pressure since a two-day, roughly 29% plunge in early July tied to heavy insider selling (about $35.9 million over three months with no offsetting purchases) and the CFO's announced retirement, effective August 31, 2026.
  • Arteris' Q2 2026 earnings, reported August 11, beat on Revenue ($24.1 million versus $22.0 million consensus) but missed on the bottom line, with a non-GAAP loss of $0.10 per share versus an expected $0.06 loss, driven partly by a one-time $1.7 million French Payroll Tax tied to RSU vesting.
  • Management raised full-year 2026 revenue guidance to $95-$98 million (37% year-over-year growth) and said the company could reach non-GAAP operating profitability as soon as the fourth quarter, but investors have continued to focus on near-term Margin pressure and the stock's still-elevated valuation.

A Steep Unwind From 2026 Highs Continues

Arteris shares are down about 9.22% on Tuesday to roughly $25.27, extending a slide that has taken the stock well off its 2026 highs above $50. The pullback began in earnest in early July, when Arteris plunged roughly 29% over two trading days on news of heavy insider selling — about $35.9 million in stock sold by executives over three months, including CEO K. Charles Janac and then-CFO Nicholas Hawkins, with no offsetting insider purchases — alongside the announcement that the CFO would retire effective August 31, 2026, citing a family illness.

Q2 Earnings Beat Revenue But Missed On Profitability

Arteris reported second-quarter 2026 results on August 11: revenue of $24.1 million beat the $22.0 million consensus by nearly 10%, but the company posted a non-GAAP loss of $0.10 per share versus an expected $0.06 loss. Management attributed the shortfall to an unexpected $1.7 million French employer payroll tax tied to RSU vesting, elevated sales commissions from strong deal flow, and lower margins on government contract work. Shares initially closed up 2.59% on the earnings date but fell roughly 5.31% in after-hours trading as investors focused on the profitability miss.

Raised Guidance Hasn't Stopped The Selling

Despite the earnings-day stumble, Arteris raised its full-year 2026 revenue guidance to $95-$98 million, representing about 37% year-over-year growth, and management said the company could reach non-GAAP operating profitability as early as the fourth quarter of 2026. However, the stock's price-to-sales ratio had ballooned to more than 22 times at its summer peak versus an industry median closer to 5, and with the company still unprofitable, investors appear to be continuing to reprice the shares lower even as bookings and Backlog remain at record levels.

Bottom Line

Arteris' roughly 9% drop today to $25.27 extends a pullback that began with heavy insider selling and a CFO transition in early July and continued after a mixed August 11 earnings report that beat on revenue but missed on profitability. Raised full-year guidance and record bookings have so far not been enough to offset concerns about near-term margin pressure and a still-rich valuation. These are the verified facts as reported. Whether the pullback extends may depend on whether Arteris can deliver on its target of reaching non-GAAP operating profitability by the fourth quarter of 2026.